Overview
Tuo Li practices practicing medicine in Changzheng, China.
Li is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Graves Disease, Hyperthyroidism, Hereditary Pancreatitis, and Pancreatic Cancer.
They are actively involved in clinical research, co-authoring 25 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Tuo Li
Is Tuo Li a top-rated expert for Graves Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Tuo Li is classified as an Advanced expert for Graves Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Tuo Li participate in research or clinical trials?
Yes. Tuo Li has published 25 articles and abstracts on conditions like Graves Disease. You can view a list of Tuo Li's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Graves DiseaseLi isAdvanced. Learn about Graves Disease.
- HyperthyroidismLi isAdvanced. Learn about Hyperthyroidism.
- Experienced
- Hereditary PancreatitisLi isExperienced. Learn about Hereditary Pancreatitis.
- Pancreatic CancerLi isExperienced. Learn about Pancreatic Cancer.